The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma.

Pan, Hui; Byers, Joshua; Yin, Hong; Rytting, Heather; Logan, Suzanna; He, Mai; Yu, Zhongxin; Wang, Dehua; Mangray, Shamlal; Zhou, Shengmei

Pan, Hui; Byers, Joshua; Yin, Hong; Rytting, Heather; Logan, Suzanna; He, Mai; Yu, Zhongxin; Wang, Dehua; Mangray, Shamlal; Zhou, Shengmei.

Afiliación

Pan H; Department of Pathology and Laboratory Medicine, USC/LAC+USC Medical Center Los Angeles, CA, USA.
Byers J; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles CA, USA.
Yin H; Children's Healthcare of Atlanta Atlanta, Georgia, USA.
Rytting H; Children's Healthcare of Atlanta Atlanta, Georgia, USA.
Logan S; Children's Healthcare of Atlanta Atlanta, Georgia, USA.
He M; Washington University in Saint Louis Saint Louis, Missouri, USA.
Yu Z; University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, USA.
Wang D; Cincinnati Children's Hospital Cincinnati, Ohio, USA.
Mangray S; Rhode Island Hospital Providence, Rhode Island, USA.
Zhou S; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles CA, USA.

Int J Clin Exp Pathol ; 16(2): 32-39, 2023.

Article en En | MEDLINE | ID: mdl-36910892

Palabras clave

Angiomatoid fibrous histiocytoma; BCOR; TLE1; immunohistochemical staining; pitfalls; utility

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Int J Clin Exp Pathol Asunto de la revista: PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google